Bacillus anthracis is the etiological agent for anthrax, a serious, frequently fatal disease which infects many mammalian species, including humans. The virulence of anthrax bacilli is due to the production of a three-component protein exotoxin (16, 17, 20) and a poly-D-glutamic acid capsule (23). The toxin proteins have been purified and consist of a protective antigen (PA), an edema factor (EF), and a lethal factor (LF) (1, 4, 17) . Although none of these proteins is toxic individually, the combination of PA and LF causes death in rats, guinea pigs, and mice (1, 10) , and PA interacts with EF to produce localized edema in the skin of guinea pigs and rabbits (16, 20) . PA binds to cell surface receptors, is activated by proteolytic cleavage, and then binds either LF or EF. The resultant binary complex then apparently enters the cell by endocytosis (5, 8, 9 ; S. H. Leppla and A. M. Friedlander, personal communications).
Since many bacterial toxins are plasmid encoded, Mikesell et al. (13) examined several different B. anthracis strains for extrachromosomal DNA. A large plasmid (pXO1) required for toxin production was isolated. The recent cloning of the PA (21) and LF (15) genes from a pXO1 recombinant DNA library clearly demonstrated that these toxin genes are plasmid encoded. Green et al. (6) recently identified an additional smaller plasmid (pXO2) required for capsule production. B. anthracis strains which contain only one of these plasmids are avirulent. For example, the Sterne strain, which contains only pXO1 and produces toxin but no capsule (Tox+, Cap-) , is used as the current anthrax veterinary vaccine (8, 18) . Another avirulent strain, the Pasteur vaccine strain (ATCC 6602), contains pXO2 (6) and produces capsule but no toxin (Tox-, Cap').
The B. anthracis EF is responsible for the edematous lesions in cutaneous anthrax, and biochemical analysis has shown that it is a calmodulin-dependent adenylate cyclase (7) (8) (9) . This activity, however, was originally obscured, since EF alone, or even in combination with PA, displays no enzymatic activity in vitro. Activation of the enzyme requires exposure to components from a eucaryotic cell lysate, specifically calmodulin, a mammalian calcium-binding protein. EF, therefore, is a bacterial adenylate cyclase that is active only in the presence of the eucaryotic cofactor, calmodulin. The adenylate cyclase from Bordetella per-tussis, the etiological agent for whooping cough, is also calmodulin dependent (22) . The role of these enzymes in the pathogenesis of these bacteria and other organisms which increase intracellular cyclic AMP levels (14) is unknown.
The toxin genes for PA (21) and LF (15) have been cloned, but the EF gene has not. PA and LF are easily detected in Escherichia coli by using immunological methods (3), but EF could not be detected in recombinant DNA libraries grown in E. coli. The apparent lack of success in cloning EF could have several explanations: (i) the EF gene could be coded for by chromosomal DNA, (ii) the EF gene could have a promoter or translation initiation sequence which is not recognized by E. coli, or (iii) the gene could be preferentially cleaved during library generation. In this communication, we report the cloning and expression of the EF gene.
MATERIALS AND METHODS
Reagents and enzymes. The DNA restriction and modifying enzymes were obtained from Bethesda Research Laboratories, Inc. 32P-labeled nucleotides and GeneScreenPlus were obtained from New England Nuclear Corp. Nitrocellulose membranes were obtained from Schleicher & Schuell, Inc. Reagents used for electrophoresis, cell growth, buffers, and biochemical analysis were analytical-reagent quality.
Generation of recombinant DNA library. The B. anthracis toxin plasmid, pXO1, was prepared from B. anthracis Sterne as described previously (21) . Recombinant plasmid pSE42, which contains a 6.5 kilobase-pair (kbp) BamHI DNA fragment cloned into pBR322 (21) , was provided by M. Vodkin. Plasmids pEF68, pEF194, and pEF215 were isolated from the recombinant DNA library of pXO1 as described previously (15) . E. coli containing the pXO1-derived recombinant plasmids were grown on an L-agar plate. These bacteria were transferred to nitrocellulose filters, lysed, and immunologically screened (3, 15) . Nitrocellulose filters of identically grided plates were prepared for hybridization (11) with a synthetic EF-specific oligonucleotide which had been labeled with [_y-32P]ATP and T4 polynucleotide kinase. The filters were hybridized overnight at 30°C with the labeled oligonucleotide (5'-ATGAAPGAXCAPTAP-3', in which X = G,A and P = T,C), which was specific for the first five amino acids of EF (Met-Asn-Glu-His-Tyr; determined by J. Schmidt [U.S. Army Medical Research Institute of Infectious Diseases]), in 6x SSPE (11)S5x Denhardt solution-0.5% sodium dodecyl sulfate. After hybridization, the filters were washed three times for 15 min in 6x SSPE-0.5% sodium dodecyl sulfate at 30°C. Autoradiography was performed overnight at -70°C with XAR-5 film (Eastman Kodak Co.).
Determination of EF gene orientation and primer elongation. Two plasmids (pEF2.2-29 and pEF2.2-30) were constructed by cloning the 2.2-kbp HindlIl fragment from pSE42 (see Fig. 1 ), which hybridized to the EF oligonucleotide, into pTZ18R (12) . Single-stranded DNA from these plasmids was transferred to nitrocellulose membranes and hybridized to the radiolabeled EF oligonucleotide (11) . For primer elongation studies, the radiolabeled oligonucleotide was combined with single-stranded pEF2.2-29 and elongated by using Klenow fragment of E. coli DNA polymerase I (with unlabeled deoxynucleoside triphosphates) under standard DNA polymerase reaction conditions. After a 60-min incubation at 37°C, the DNA mixture was ethanol precipitated, dissolved in restriction enzyme buffer, and digested with either XbaI, EcoRI, or HindIII. Samples from these digestion reactions were electrophoresed in a 4% denaturing polyacrylamide gel (11) for DNA size determinations.
Construction of a plasmid which expressed EF in E. coli. The 4-kbp EcoRI-to-BamHI fragment from pSE42 (see Fig.  1 ) was subcloned into pTZ18R (12) . This plasmid construction (designated pEF42) positioned the start of the EF gene about 350 bases downstream from the lac promoter. This recombinant plasmid, when transformed into E. coli TB1 (Bethesda Research Laboratories), produced immunologically detectable EF (3, 15) . Recombinant E. coli was sonicated, and the resultant lysate was used in an EF adenylate cyclase assay (7, 8) . RESULTS Isolation of recombinant plasmids which contained the EF gene. To identify recombinant plasmids which produced EF, a recombinant DNA library of pXO1 was screened immunologically by using EF-specific rabbit antiserum (15) . After 244 randomly selected colonies were screened, none were positive for EF, whereas several were positive for either PA or LF (15) . Since we could not detect the production of EF immunologically, we attempted to identify plasmids which contained at least part of the EF gene by using oligonucleotide hybridization. The oligonucleotide we used was specific for the first five amino acids of mature EF. Each of the 244 recombinant E. coli colonies was transferred to nitrocellulose filters and hybridized with the radiolabeled EF oligonucleotide (15) . Following autoradiography, bacterial colonies which had intensities higher than the background intensity were isolated. From subsequent experiments, three of these bacterial colonies contained EF-specific DNA (pEF68, pEF194, and pEF215). Another recombinant plasmid, pSE42, also hybridized to this oligonucleotide.
After we identified plasmids which contained at least part of the EF gene, we used molecular hybridization to show that the EF gene was present on pXO1. The radiolabeled oligonucleotide and the EF-containing plasmids were used as probes to hybridize to enzyme-cleaved pXOl or B. anthracis chromosomal DNA. The results of these experiments showed that the EF gene was present on pXO1 and that EF gene sequences were not present in chromosomal DNA (data not shown). Taken together with previous results (15), we have now shown that each of the anthrax toxin proteins is plasmid encoded. The EF gene has been mapped and was located about 30 kbp from the PA and LF genes (which are located next to each other) on the pXO1 restriction map (D. L. Robertson and S. Simpson, unpublished data).
Restriction enzyme analysis of EF recombinant DNAs. DNA for each of the EF recombinant plasmids was isolated by using the alkaline lysis method of Birnboim and Doly (2). The restriction map for pSE42, which contains a 6.5-kbp BamHI insert, is shown in Fig. 1 . When the restriction map for each of the other EF recombinant plasmids was determined, it was found that each plasmid contained a DNA insert which mapped entirely within the 6.5-kbp insert of pSE42. In addition, we observed an area of overlap for each plasmid, which corresponded to the region where the EF oligonucleotide hybridized and the EF gene started. Since pSE42 is large enough to encode a full-length EF protein (about 2,400 nucleotides would be required), further DNA analysis was performed with DNA derived from this plasmid.
The EF oligonucleotide hybridized to the 2.2-kbp HindIII fragment (designated EF2.2 in Fig. 1 ) from pSE42. However, the direction of transcription and the exact position for the start of the EF gene were not known. EF2.2 was cloned in both orientations into pTZ18R (12) , and these plasmids were designated pEF2.2-29 and pEF2.2-30. Since pTZ18R contains the intergenic region from bacteriophage fl, superinfection of cells carrying this plasmid with wild-type M13 produces single-stranded plasmid DNA which can be used for strand-specific hybridization (12) . Consequently, singlestranded DNA containing either the top or bottom strand of a DNA fragment can be individually isolated and characterized. On the basis of the orientation of the HindIl insert in these plasmids, single-stranded DNA prepared from pEF2.2-29 proceeded in a 5'-*3' clockwise direction, exactly as depicted for the orientation of EF2.2 ( Fig. 1) but not pEF2.2-30, hybridized with this probe (data not shown). Therefore, since single-stranded DNA produced from pEF2.2-29 was oriented in a 5'--3' clockwise direction, EF gene transcription must have proceeded in the opposite or counterclockwise orientation. Primer elongation experiments support this conclusion.
For primer elongation, the labeled EF oligonucleotide was hybridized to single-stranded pEF2.2-29 and then polymerized with the Klenow fragment of DNA polymerase I. Since the oligonucleotide is specific for the amino terminus of EF, elongation of this primer will proceed in the same direction as gene transcription. Following polymerization, the endlabeled DNA was treated with HindIlI, XbaI or EcoRI. The size of the DNA from the labeled primer to the HindIII cleavage site was 810 bp (Fig. 2) . Cleavage of the elongation product with XbaI generated a fragment which was 461 bp. However, when the polymerized DNA was treated with EcoRI, the DNA was not cleaved. Therefore, the amino terminus of the EF gene was located between the XbaI and EcoRI cleavage sites and was 810 bp to the right of the HindIll recognition site. These results show that EF gene transcription was counterclockwise (as depicted in Fig. 1 ) and that pSE42 contained enough DNA from the oligonucleotide-binding site to encode the entire EF protein.
Expression of the EF gene in E. coli. Although pSE42 contains the entire EF gene, we have not been able to detect EF in E. coli carrying this plasmid. Consequently, it is likely 1 2 3 4 bp a.
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a The strain number is the laboratory designation for the bacteria containing the particular plasmid. Recombinant E. coli was grown for 2 h with 1 mM isopropyl-o-D-thiogalactopyranoside. The recombinant EF produced by TB1(pEF42) was expressed from the lac promoter of pTZ18R. EF activity present in the two different BL21(pEF42) isolates used T7 polymerase (19) to transcribe the EF gene for mRNA synthesis. Purified EF was prepared from B. anthracis culture supernatants and was provided by S. Leppla. b The amount of radioactivity present in 3H-labeled cyclic AMP for these experiments was determined by using the calmodulin-dependent adenylate cyclase assay (7, 8) . Endogenous adenylate cyclase activity from E. coli lacking pEF42 [e.g., TB1(pTZ18R)J produced background levels of 3H-labeled cyclic AMP, either in the absence or presence of calmodulin.
that the normal B. anthracis promoter for EF, if present on this DNA fragment, does not function in E. coli. Therefore, we attempted to get expression by fusing the EF gene to the lac promoter in pTZ18R. The EcoRI-to-BamHI fragment from pSE42, which contains the entire EF gene, was cloned into pTZ18R. This construction, designated pEF42, positioned the start of the EF gene about 350 bases downstream from the lac promoter. When pEF42 was grown in E. coli TB1, EF was detected by a membrane-bound enzyme-linked immunosorbent assay (3, 15) . Isopropyl-p-D-thiogalactopyranoside seemed to augment the production of EF (data not shown), but a precise quantification was not determined. pTZ18R also contains the T7 RNA polymerase promoter located between the lac promoter and the EcoRI cleavage site. By using E. coli BL21 (19) , which contains an integrated copy of T7 RNA polymerase regulated by the lac promoter (provided by W. Studier, Brookhaven National Laboratories), we monitored the expression of EF from pEF42 after treatment with isopropyl-,-D-thiogalactopyranoside (19) . EF was produced in recombinant E. coli(pEF42) ( Table 1) . From the results of these experiments, it should be noted that our adenylate cyclase assay (7, 8) appeared to be specific for EF and that endogenous E. coli adenylate cyclase activity was at background levels.
Finally, the full-length EF (89 kilodaltons) was also detected in Western blots (immunoblots) (Fig. 3) . In control experiments using these same antibodies, E. coli which did not carry pEF42 contained no protein band of this size (data not shown). These data clearly show that the entire EF gene was contained on the DNA fragment cloned into pEF42 and that recombinant EF could be produced in E. coli in active form. lated in E. coli, the failure of earlier cloning studies to detect EF gene expression apparently reflected the inability of the EF gene to be transcribed in E. coli.
The EF gene, like the PA and LF genes, was present on the large B. anthracis toxin plasmid pXO1. By using restriction enzyme and hybridization analysis, we have determined that each of these genes was present only once on this plasmid and that closely related sequences were not present in genomic DNA (unpublished data of authors). The PA and LF genes were located next to each other and were about 30 kbp removed from the EF gene (Robertson and Simpson, unpublished data).
Each of the B. anthracis toxin genes has now been cloned. The overall goal of these experiments is the construction of a safe, nontoxic vaccine strain. The approach that we are using involves the use of site-specific mutagenesis techniques to specifically alter these DNAs so that the modified genes will produce proteins which are nonfunctional as toxin components, but which are still fully immunogenic. Once identified, these mutant genes can be placed back into B. anthracis and used as prototype vaccine strains.
